▶ 調査レポート

患者腫瘍組織移植モデル/ PDXモデルの世界市場:市場規模・現状・予測

• 英文タイトル:Global Patient Derived Xenograft/PDX Models Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。患者腫瘍組織移植モデル/ PDXモデルの世界市場:市場規模・現状・予測 / Global Patient Derived Xenograft/PDX Models Market Size, Status and Forecast 2019-2025 / QYR9ST04234資料のイメージです。• レポートコード:QYR9ST04234
• 出版社/出版日:QYResearch / 2019年9月2日
• レポート形態:英文、PDF、91ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥405,600 (USD3,900)▷ お問い合わせ
  Enterprise License¥811,200 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※当調査レポートでは、患者腫瘍組織移植モデル/ PDXモデルの世界市場について調査・分析し、患者腫瘍組織移植モデル/ PDXモデルの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(マウスモデル、ラットモデル)、用途別(前臨床医薬品開発及び基礎癌研究、バイオマーカー分析)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の患者腫瘍組織移植モデル/ PDXモデル市場動向
・主要企業別マーケットシェア
・患者腫瘍組織移植モデル/ PDXモデルの種類別市場規模2014-2019
(マウスモデル、ラットモデル)
・患者腫瘍組織移植モデル/ PDXモデルの用途別市場規模2014-2019
(前臨床医薬品開発及び基礎癌研究、バイオマーカー分析)
・患者腫瘍組織移植モデル/ PDXモデルの北米市場:主要企業・種類別/用途別市場規模
・患者腫瘍組織移植モデル/ PDXモデルのヨーロッパ市場:主要企業・種類別/用途別市場規模
・患者腫瘍組織移植モデル/ PDXモデルの中国市場:主要企業・種類別/用途別市場規模
・患者腫瘍組織移植モデル/ PDXモデルの日本国内市場:主要企業・種類別/用途別市場規模
・患者腫瘍組織移植モデル/ PDXモデルの東南アジア市場:主要企業・種類別/用途別市場規模
・患者腫瘍組織移植モデル/ PDXモデルのインド市場:主要企業・種類別/用途別市場規模
・患者腫瘍組織移植モデル/ PDXモデルの中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Crown Bioscience、The Jackson Laboratory、Champions Oncology、Charles River Laboratories、WuXi Apptec、Oncodesign、Horizon Discovery、Pharmatest Services、Hera Biolabs、EPO Berlin-Buch、Xentech、Urolead)
・患者腫瘍組織移植モデル/ PDXモデルの市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...

Patient derived xenografts (PDX) are models of cancer where the tissue or cells from a patient’s tumor are implanted into an immunodeficient or humanized mouse. PDX models are used to create an environment that allows for the natural growth of cancer, its monitoring, and corresponding treatment evaluations for the original patient.Several types of immunodeficient mice can be used to establish PDX models: athymic nude mice, severely compromised immune deficient (SCID) mice, NOD-SCID mice, and recombination-activating gene 2 (Rag2)-knockout mice. The mice used must be immunocompromised to prevent transplant rejection. The NOD-SCID mouse is considered more immunodeficient than the nude mouse, and therefore is more commonly used for PDX models because the NOD-SCID mouse does not produce natural killer cells.
In 2018, the global Patient Derived Xenograft/PDX Models market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Patient Derived Xenograft/PDX Models status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Patient Derived Xenograft/PDX Models development in United States, Europe and China.

The key players covered in this study
Crown Bioscience
The Jackson Laboratory
Champions Oncology
Charles River Laboratories
WuXi Apptec
Oncodesign
Horizon Discovery
Pharmatest Services
Hera Biolabs
EPO Berlin-Buch
Xentech
Urolead

Market segment by Type, the product can be split into
Mice Models
Rat Models

Market segment by Application, split into
Pre-clinical Drug Development and Basic Cancer Research
Biomarker Analysis

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Patient Derived Xenograft/PDX Models status, future forecast, growth opportunity, key market and key players.
To present the Patient Derived Xenograft/PDX Models development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Patient Derived Xenograft/PDX Models are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Patient Derived Xenograft/PDX Models Market Size Growth Rate by Type (2014-2025)
1.4.2 Mice Models
1.4.3 Rat Models
1.5 Market by Application
1.5.1 Global Patient Derived Xenograft/PDX Models Market Share by Application (2014-2025)
1.5.2 Pre-clinical Drug Development and Basic Cancer Research
1.5.3 Biomarker Analysis
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Patient Derived Xenograft/PDX Models Market Size
2.2 Patient Derived Xenograft/PDX Models Growth Trends by Regions
2.2.1 Patient Derived Xenograft/PDX Models Market Size by Regions (2014-2025)
2.2.2 Patient Derived Xenograft/PDX Models Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Patient Derived Xenograft/PDX Models Market Size by Manufacturers
3.1.1 Global Patient Derived Xenograft/PDX Models Revenue by Manufacturers (2014-2019)
3.1.2 Global Patient Derived Xenograft/PDX Models Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Patient Derived Xenograft/PDX Models Market Concentration Ratio (CR5 and HHI)
3.2 Patient Derived Xenograft/PDX Models Key Players Head office and Area Served
3.3 Key Players Patient Derived Xenograft/PDX Models Product/Solution/Service
3.4 Date of Enter into Patient Derived Xenograft/PDX Models Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Patient Derived Xenograft/PDX Models Market Size by Type (2014-2019)
4.2 Global Patient Derived Xenograft/PDX Models Market Size by Application (2014-2019)

5 United States
5.1 United States Patient Derived Xenograft/PDX Models Market Size (2014-2019)
5.2 Patient Derived Xenograft/PDX Models Key Players in United States
5.3 United States Patient Derived Xenograft/PDX Models Market Size by Type
5.4 United States Patient Derived Xenograft/PDX Models Market Size by Application

6 Europe
6.1 Europe Patient Derived Xenograft/PDX Models Market Size (2014-2019)
6.2 Patient Derived Xenograft/PDX Models Key Players in Europe
6.3 Europe Patient Derived Xenograft/PDX Models Market Size by Type
6.4 Europe Patient Derived Xenograft/PDX Models Market Size by Application

7 China
7.1 China Patient Derived Xenograft/PDX Models Market Size (2014-2019)
7.2 Patient Derived Xenograft/PDX Models Key Players in China
7.3 China Patient Derived Xenograft/PDX Models Market Size by Type
7.4 China Patient Derived Xenograft/PDX Models Market Size by Application

8 Japan
8.1 Japan Patient Derived Xenograft/PDX Models Market Size (2014-2019)
8.2 Patient Derived Xenograft/PDX Models Key Players in Japan
8.3 Japan Patient Derived Xenograft/PDX Models Market Size by Type
8.4 Japan Patient Derived Xenograft/PDX Models Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Patient Derived Xenograft/PDX Models Market Size (2014-2019)
9.2 Patient Derived Xenograft/PDX Models Key Players in Southeast Asia
9.3 Southeast Asia Patient Derived Xenograft/PDX Models Market Size by Type
9.4 Southeast Asia Patient Derived Xenograft/PDX Models Market Size by Application

10 India
10.1 India Patient Derived Xenograft/PDX Models Market Size (2014-2019)
10.2 Patient Derived Xenograft/PDX Models Key Players in India
10.3 India Patient Derived Xenograft/PDX Models Market Size by Type
10.4 India Patient Derived Xenograft/PDX Models Market Size by Application

11 Central & South America
11.1 Central & South America Patient Derived Xenograft/PDX Models Market Size (2014-2019)
11.2 Patient Derived Xenograft/PDX Models Key Players in Central & South America
11.3 Central & South America Patient Derived Xenograft/PDX Models Market Size by Type
11.4 Central & South America Patient Derived Xenograft/PDX Models Market Size by Application

12 International Players Profiles
12.1 Crown Bioscience
12.1.1 Crown Bioscience Company Details
12.1.2 Company Description and Business Overview
12.1.3 Patient Derived Xenograft/PDX Models Introduction
12.1.4 Crown Bioscience Revenue in Patient Derived Xenograft/PDX Models Business (2014-2019)
12.1.5 Crown Bioscience Recent Development
12.2 The Jackson Laboratory
12.2.1 The Jackson Laboratory Company Details
12.2.2 Company Description and Business Overview
12.2.3 Patient Derived Xenograft/PDX Models Introduction
12.2.4 The Jackson Laboratory Revenue in Patient Derived Xenograft/PDX Models Business (2014-2019)
12.2.5 The Jackson Laboratory Recent Development
12.3 Champions Oncology
12.3.1 Champions Oncology Company Details
12.3.2 Company Description and Business Overview
12.3.3 Patient Derived Xenograft/PDX Models Introduction
12.3.4 Champions Oncology Revenue in Patient Derived Xenograft/PDX Models Business (2014-2019)
12.3.5 Champions Oncology Recent Development
12.4 Charles River Laboratories
12.4.1 Charles River Laboratories Company Details
12.4.2 Company Description and Business Overview
12.4.3 Patient Derived Xenograft/PDX Models Introduction
12.4.4 Charles River Laboratories Revenue in Patient Derived Xenograft/PDX Models Business (2014-2019)
12.4.5 Charles River Laboratories Recent Development
12.5 WuXi Apptec
12.5.1 WuXi Apptec Company Details
12.5.2 Company Description and Business Overview
12.5.3 Patient Derived Xenograft/PDX Models Introduction
12.5.4 WuXi Apptec Revenue in Patient Derived Xenograft/PDX Models Business (2014-2019)
12.5.5 WuXi Apptec Recent Development
12.6 Oncodesign
12.6.1 Oncodesign Company Details
12.6.2 Company Description and Business Overview
12.6.3 Patient Derived Xenograft/PDX Models Introduction
12.6.4 Oncodesign Revenue in Patient Derived Xenograft/PDX Models Business (2014-2019)
12.6.5 Oncodesign Recent Development
12.7 Horizon Discovery
12.7.1 Horizon Discovery Company Details
12.7.2 Company Description and Business Overview
12.7.3 Patient Derived Xenograft/PDX Models Introduction
12.7.4 Horizon Discovery Revenue in Patient Derived Xenograft/PDX Models Business (2014-2019)
12.7.5 Horizon Discovery Recent Development
12.8 Pharmatest Services
12.8.1 Pharmatest Services Company Details
12.8.2 Company Description and Business Overview
12.8.3 Patient Derived Xenograft/PDX Models Introduction
12.8.4 Pharmatest Services Revenue in Patient Derived Xenograft/PDX Models Business (2014-2019)
12.8.5 Pharmatest Services Recent Development
12.9 Hera Biolabs
12.9.1 Hera Biolabs Company Details
12.9.2 Company Description and Business Overview
12.9.3 Patient Derived Xenograft/PDX Models Introduction
12.9.4 Hera Biolabs Revenue in Patient Derived Xenograft/PDX Models Business (2014-2019)
12.9.5 Hera Biolabs Recent Development
12.10 EPO Berlin-Buch
12.10.1 EPO Berlin-Buch Company Details
12.10.2 Company Description and Business Overview
12.10.3 Patient Derived Xenograft/PDX Models Introduction
12.10.4 EPO Berlin-Buch Revenue in Patient Derived Xenograft/PDX Models Business (2014-2019)
12.10.5 EPO Berlin-Buch Recent Development
12.11 Xentech
12.12 Urolead

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Patient Derived Xenograft/PDX Models Key Market Segments
Table Key Players Patient Derived Xenograft/PDX Models Covered
Table Global Patient Derived Xenograft/PDX Models Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Patient Derived Xenograft/PDX Models Market Size Market Share by Type 2014-2025
Figure Mice Models Figures
Table Key Players of Mice Models
Figure Rat Models Figures
Table Key Players of Rat Models
Table Global Patient Derived Xenograft/PDX Models Market Size Growth by Application 2014-2025 (Million US$)
Figure Pre-clinical Drug Development and Basic Cancer Research Case Studies
Figure Biomarker Analysis Case Studies
Figure Patient Derived Xenograft/PDX Models Report Years Considered
Table Global Patient Derived Xenograft/PDX Models Market Size 2014-2025 (Million US$)
Figure Global Patient Derived Xenograft/PDX Models Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Patient Derived Xenograft/PDX Models Market Size by Regions 2014-2025 (Million US$)
Table Global Patient Derived Xenograft/PDX Models Market Size by Regions 2014-2019 (Million US$)
Table Global Patient Derived Xenograft/PDX Models Market Share by Regions 2014-2019
Figure Global Patient Derived Xenograft/PDX Models Market Share by Regions 2014-2019
Figure Global Patient Derived Xenograft/PDX Models Market Share by Regions 2019
Table Market Top Trends
Table Global Patient Derived Xenograft/PDX Models Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Patient Derived Xenograft/PDX Models Market Share by Manufacturers (2014-2019)
Figure Global Patient Derived Xenograft/PDX Models Market Share by Manufacturers in 2018
Table Global Patient Derived Xenograft/PDX Models Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Patient Derived Xenograft/PDX Models Product/Solution/Service
Table Date of Enter into Patient Derived Xenograft/PDX Models Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Patient Derived Xenograft/PDX Models Market Size by Type (2014-2019) (Million US$)
Table Global Patient Derived Xenograft/PDX Models Market Size Share by Type (2014-2019)
Figure Global Patient Derived Xenograft/PDX Models Market Size Market Share by Type (2014-2019)
Table Global Patient Derived Xenograft/PDX Models Market Size by Application (2014-2019) (Million US$)
Table Global Patient Derived Xenograft/PDX Models Market Size Share by Application (2014-2019)
Figure Global Patient Derived Xenograft/PDX Models Market Size Market Share by Application (2014-2019)
Figure Global Patient Derived Xenograft/PDX Models Revenue Market Share by Application in 2018
Figure United States Patient Derived Xenograft/PDX Models Market Size 2014-2019 (Million US$)
Table United States Key Players Patient Derived Xenograft/PDX Models Revenue (2018-2019) (Million US$)
Table United States Key Players Patient Derived Xenograft/PDX Models Market Share (2018-2019)
Table United States Patient Derived Xenograft/PDX Models Market Size by Type (2014-2019) (Million US$)
Table United States Patient Derived Xenograft/PDX Models Market Share by Type (2014-2019)
Table United States Patient Derived Xenograft/PDX Models Market Size by Application (2014-2019) (Million US$)
Table United States Patient Derived Xenograft/PDX Models Market Share by Application (2014-2019)
Figure Europe Patient Derived Xenograft/PDX Models Market Size 2014-2019 (Million US$)
Table Europe Key Players Patient Derived Xenograft/PDX Models Revenue (2018-2019) (Million US$)
Table Europe Key Players Patient Derived Xenograft/PDX Models Market Share (2018-2019)
Table Europe Patient Derived Xenograft/PDX Models Market Size by Type (2014-2019) (Million US$)
Table Europe Patient Derived Xenograft/PDX Models Market Share by Type (2014-2019)
Table Europe Patient Derived Xenograft/PDX Models Market Size by Application (2014-2019) (Million US$)
Table Europe Patient Derived Xenograft/PDX Models Market Share by Application (2014-2019)
Figure China Patient Derived Xenograft/PDX Models Market Size 2014-2019 (Million US$)
Table China Key Players Patient Derived Xenograft/PDX Models Revenue (2018-2019) (Million US$)
Table China Key Players Patient Derived Xenograft/PDX Models Market Share (2018-2019)
Table China Patient Derived Xenograft/PDX Models Market Size by Type (2014-20189) (Million US$)
Table China Patient Derived Xenograft/PDX Models Market Share by Type (2014-2019)
Table China Patient Derived Xenograft/PDX Models Market Size by Application (2014-2019) (Million US$)
Table China Patient Derived Xenograft/PDX Models Market Share by Application (2014-2019)
Figure Japan Patient Derived Xenograft/PDX Models Market Size 2014-2019 (Million US$)
Table Japan Key Players Patient Derived Xenograft/PDX Models Revenue (2018-2019) (Million US$)
Table Japan Key Players Patient Derived Xenograft/PDX Models Market Share (2018-2019)
Table Japan Patient Derived Xenograft/PDX Models Market Size by Type (2014-2019) (Million US$)
Table Japan Patient Derived Xenograft/PDX Models Market Share by Type (2014-2019)
Table Japan Patient Derived Xenograft/PDX Models Market Size by Application (2014-2019) (Million US$)
Table Japan Patient Derived Xenograft/PDX Models Market Share by Application (2014-2019)
Figure Southeast Asia Patient Derived Xenograft/PDX Models Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Patient Derived Xenograft/PDX Models Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Patient Derived Xenograft/PDX Models Market Share (2018-2019)
Table Southeast Asia Patient Derived Xenograft/PDX Models Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Patient Derived Xenograft/PDX Models Market Share by Type (2014-2019)
Table Southeast Asia Patient Derived Xenograft/PDX Models Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Patient Derived Xenograft/PDX Models Market Share by Application (2014-2019)
Figure India Patient Derived Xenograft/PDX Models Market Size 2014-2019 (Million US$)
Table India Key Players Patient Derived Xenograft/PDX Models Revenue (2018-2019) (Million US$)
Table India Key Players Patient Derived Xenograft/PDX Models Market Share (2018-2019)
Table India Patient Derived Xenograft/PDX Models Market Size by Type (2014-2019) (Million US$)
Table India Patient Derived Xenograft/PDX Models Market Share by Type (2014-2019)
Table India Patient Derived Xenograft/PDX Models Market Size by Application (2014-2019) (Million US$)
Table India Patient Derived Xenograft/PDX Models Market Share by Application (2014-2019)
Figure Central & South America Patient Derived Xenograft/PDX Models Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Patient Derived Xenograft/PDX Models Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Patient Derived Xenograft/PDX Models Market Share (2018-2019)
Table Central & South America Patient Derived Xenograft/PDX Models Market Size by Type (2014-2019) (Million US$)
Table Central & South America Patient Derived Xenograft/PDX Models Market Share by Type (2014-2019)
Table Central & South America Patient Derived Xenograft/PDX Models Market Size by Application (2014-2019) (Million US$)
Table Central & South America Patient Derived Xenograft/PDX Models Market Share by Application (2014-2019)
Table Crown Bioscience Company Details
Table Crown Bioscience Revenue in Patient Derived Xenograft/PDX Models Business (2014-2019) (Million US$)
Figure Crown Bioscience Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2014-2019)
Table Crown Bioscience Recent Development
Table The Jackson Laboratory Company Details
Table The Jackson Laboratory Revenue in Patient Derived Xenograft/PDX Models Business (2014-2019)(Million US$)
Figure The Jackson Laboratory Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2014-2019)
Table The Jackson Laboratory Recent Development
Table Champions Oncology Company Details
Table Champions Oncology Revenue in Patient Derived Xenograft/PDX Models Business (2014-2019)(Million US$)
Figure Champions Oncology Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2014-2019)
Table Champions Oncology Recent Development
Table Charles River Laboratories Company Details
Table Charles River Laboratories Revenue in Patient Derived Xenograft/PDX Models Business (2014-2019)(Million US$)
Figure Charles River Laboratories Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2014-2019)
Table Charles River Laboratories Recent Development
Table WuXi Apptec Company Details
Table WuXi Apptec Revenue in Patient Derived Xenograft/PDX Models Business (2014-2019)(Million US$)
Figure WuXi Apptec Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2014-2019)
Table WuXi Apptec Recent Development
Table Oncodesign Company Details
Table Oncodesign Revenue in Patient Derived Xenograft/PDX Models Business (2014-2019)(Million US$)
Figure Oncodesign Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2014-2019)
Table Oncodesign Recent Development
Table Horizon Discovery Company Details
Table Horizon Discovery Revenue in Patient Derived Xenograft/PDX Models Business (2014-2019)(Million US$)
Figure Horizon Discovery Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2014-2019)
Table Horizon Discovery Recent Development
Table Pharmatest Services Company Details
Table Pharmatest Services Revenue in Patient Derived Xenograft/PDX Models Business (2014-2019)(Million US$)
Figure Pharmatest Services Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2014-2019)
Table Pharmatest Services Recent Development
Table Hera Biolabs Company Details
Table Hera Biolabs Revenue in Patient Derived Xenograft/PDX Models Business (2014-2019)(Million US$)
Figure Hera Biolabs Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2014-2019)
Table Hera Biolabs Recent Development
Table EPO Berlin-Buch Company Details
Table EPO Berlin-Buch Revenue in Patient Derived Xenograft/PDX Models Business (2014-2019)(Million US$)
Figure EPO Berlin-Buch Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2014-2019)
Table EPO Berlin-Buch Recent Development
Table Xentech Company Details
Table Urolead Company Details
Table Global Patient Derived Xenograft/PDX Models Market Size by Regions (Million US$) 2019-2025
Figure Global Patient Derived Xenograft/PDX Models Market Size Share by Regions (2019-2025)
Figure Global Patient Derived Xenograft/PDX Models Market Size Share by Regions in 2025
Figure United States Patient Derived Xenograft/PDX Models Market Size Forecast (2019-2025)(Million USD)
Figure Europe Patient Derived Xenograft/PDX Models Market Size Forecast (2019-2025)(Million USD)
Figure China Patient Derived Xenograft/PDX Models Market Size Forecast (2019-2025)(Million USD)
Figure Japan Patient Derived Xenograft/PDX Models Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Patient Derived Xenograft/PDX Models Market Size Forecast (2019-2025)(Million USD)
Figure India Patient Derived Xenograft/PDX Models Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Patient Derived Xenograft/PDX Models Market Size Forecast (2019-2025)(Million USD)
Table Global Patient Derived Xenograft/PDX Models Market Size by Product (2019-2025) (Million US$)
Figure Global Patient Derived Xenograft/PDX Models Market Size by Product (2019-2025)
Figure Global Patient Derived Xenograft/PDX Models Market Size by Product in 2025
Table Global Patient Derived Xenograft/PDX Models Market Size by Application (2019-2025) (Million US$)
Figure Global Patient Derived Xenograft/PDX Models Market Size by Application (2019-2025)
Figure Global Patient Derived Xenograft/PDX Models Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources